Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on... see more

CSE:QNTM - Post Discussion

Quantum BioPharma Ltd > Ignore the haters
View:
Post by DavidRosenberg on Jan 25, 2023 1:35pm

Ignore the haters

Hopes and dreams is that taken from the shortseller dictionary ? 


FSD has 3 tangiable biotech assets which aren't based on hopes and dreams but rather science 

FSD PEA is in recruitment phase 2 as we speak for MCAS disorder 



lucid MS and multiple sclerosis for IND submitted for phase 1 waiting from FDA to give approval so they can start recruitment for their phase 1 and hopefully help MS patients one day the holy grail of nuerodegenerative medicine for 'MS ? 


we will see , in due time

Comment by Mil_Man54 on Jan 25, 2023 3:58pm
FSD has nothing of value....just PR BS....they won't have enough funds to finish even one of the trials and there is no hope of an institutional investor or a buy out by big pharma....FSD has a very poor reputation and is toxic to investors...and don't forget Roseburg...they tried to recruit volunteers for their trials of the same compound before with ONE applicant. It's funny how you ...more  
Comment by DavidRosenberg on Jan 25, 2023 7:38pm
They have nothing of value ? Sorry but I disagree  3 biotech assets , an exceptional biotech team with Julia levy award receipiant , although I agree 2022 was terrible year for most stocks they have the fundamentals in play , recruitment has started for fsd pea phase 2 , lucid MS if it gets FDA approval for IND phase 1 then I expect recruitment to start for that too we don't yet if FDA ...more  
Comment by DavidRosenberg on Jan 25, 2023 7:43pm
 Covid 19 trials under previous ceo raza bokhari only yielded 1 patient and is  laughable  this Management wants the same result as all shareholders to create meaningful biotech to improve the world as sick patients are our neighbors , friends and family and could affect anyone so this humanitarian  mission to create new therapeutics that are not immunomodulatory like 100 ...more  
Comment by DavidRosenberg on Jan 25, 2023 7:46pm
The term is immunomodulatory - remember FSD Pharma Lucid MS is not immunomodulatory and works in a completely different way not only is that unique but 100% of drugs on market currently are immunomodulatory for multiple sclerosis   , lucid MS mechanism of action is not, but rather is a type of inhibitor that's a new chemical entity and is patent protected in USA and EU https://www ...more  
Comment by Mil_Man54 on Jan 25, 2023 8:12pm
Look at you sounding all sciency Rosenberg....all that blah...blah...blah doesn't mean anything....they have grand plans but lack the funds for the follow through....did you conveniently forget that part again....and their cracker jack team has not rpoduced dollar one in investment...no one is impressed and as long as the same scammers at the helm....nothing will change. I am also wondering ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities